Abbott: New Reasons The Split Could Tank Stock
by | Posted 5.9.2012 | Post Comment (No Comments)

Abbott Laboratories (ABT) has announcedthat it will split in two by the end of 2012. One half will be a diversified medical products company, while the other will be a research-based pharmaceutical companies. Are the two halves worth more than the whole to investors? And if you buy the company, what is the strategy after

Read the rest of this post @ DividendKings